FoxOs function synergistically to promote glucose production
Regular HbA1c monitoring will help assess whether your revised management strategy maintains adequate glycaemic control
In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future
This special plan is designed to help customers start their Mounjaro treatment with peace of mind
Our guide on cycling different peptides explains how to structure multi-peptide approaches
Champion M, Wills Avila G, Garcia AE, lvarez Delgado FM, Valdez CA